Cheryl L. Khanna

Assessment of Cumulative Incidence and Severity of Primary Open-Angle Glaucoma Among Participants in the Ocular Hypertension Treatment Study After 20 Years of Follow-up.

In this study, only one-fourth of participants in the Ocular Hypertension Treatment Study developed visual field loss in either eye over long-term follow-up.

Diplopia in Medically and Surgically Treated Patients with Glaucoma.

Diplopia may be under-recognized in medically and surgically treated patients with glaucoma, and standardization of ascertaining patient symptoms using the Diplopia Questionnaire may be useful in these patients.

The Risk of Primary Open-Angle Glaucoma Following Vitreoretinal Surgery-A Population-based Study.

The mean age was 64.7 years and the median follow-up period was 4.9 years.

Myocilin Mutations in Patients With Normal-Tension Glaucoma.

In cohorts 1 and 2, the p.Gln368Ter mutation in MYOC was found in patients with IOPs that were 21 mm Hg or lower (NTG), although at a frequency that is lower than previously detected in patients with higher IOP.

Factors Associated With Health-Related Quality of Life in Medically and Surgically Treated Patients With Glaucoma.

Our findings support the assertion that reduced HRQOL is common in surgically and medically treated patients with glaucoma.

Provider Agreement in the Assessment of Glaucoma Progression Within a Team Model.

Fair to moderate agreement levels were found among providers in their assessment of glaucoma progression, suggesting that a team approach to glaucoma management may be effective.

Need for Additional Glaucoma Surgery and Complications Following Glaucoma Drainage Device Surgery.

Glaucoma type did not significantly affect post-GDD cumulative rates of reoperation, corneal graft, and VT-complication among the OAG, PXE, and NVG groups.

Analysis of a Physician-led, Team-based Care Model for the Treatment of Glaucoma.

An increase in compliance with AAO guidelines was found after implementation of our protocol for a physician-led, team-based care model to standardize glaucoma care among providers.

Rates of Diplopia in Ahmed FP7, Baerveldt 250, and 350 Glaucoma Patients Compared With Medical Controls.

Patients with the larger (B350) or the higher profile plate (FP7) GDDs were more likely to experience diplopia than controls, and diplopia was attributable to the GDD in ~6% of patients with either a FP7 or a B350 GDD.

Comparing Surgical and Clinical Success Rates of Ahmed FP7, and Baerveldt 250 and Baerveldt 350 Glaucoma Drainage Devices.

The GDD groups were similar in their rates of success, based on both the surgical and clinical success definitions.

Rate of Corneal Grafting Post-Glaucoma Drainage Device Use in Pediatric and Adult Patients.

Adult patients were more likely to receive a corneal graft after GDD placement.

Glaucoma Drainage Devices and Reasons For Keratoplasty.

The frequency of GDDs as a reason for keratoplasty has not changed significantly between 10 years in this tertiary care setting.

Variations in Trabeculectomy and Glaucoma Drainage Device Use for the Treatment of Glaucoma in the United States.

High regional variation in trabeculectomy and GDD placement was observed.

Analysis of Standard Automated Visual Field Tests in Glaucoma and the Role of Facial Contour.

The study demonstrated the potential utility of 60-4 visual fields for identifying early functional glaucomatous changes that may not be detected by more central visual field tests (10-2 or 30-2).

Single-Use Lens Compromise During Selective Laser Trabeculoplasty.

Increased laser damage to disposable SLT lenses was associated with diminished treatment effect.

3D facial reconstruction refines 60-4 visual field assessment.

This study provides methodology for deriving a facial contour-informed 60-4 reference field and illustrates the feasibility of applying facial contour information to refine global indices of the 60-4 visual field.

The Risk of Primary Open-Angle Glaucoma Following Vitreoretinal Surgery-A Population-based Study.

Trabeculectomy-related complications in Olmsted County, Minnesota, 1985 through 2010.

The rate of trabeculectomy-related complications does not appear to be associated with mitomycin use during a mean follow-up of 7.7 years.